1.Identificatiion,Antimicrobial Susceptibility an Epidemiology of Klebsiella species Isolated from Clinical Specimen.
Young UH ; Soon Deok PARK ; Jeong Seog SON ; Hyeun Gyeo LEE ; Hyun Mi CHO ; Kap Jun YOON ; Hyo Youl KIM
Korean Journal of Clinical Microbiology 2000;3(2):99-110
BACKGROUND: In recent years, the incidence of extended-spectrum beta-lactamase (ESBL) producing Klebsiella has been steadily increased, and the newer species K. planticola and K terrigena, formerly regarded as nonpathogen, have been reported with astonishing frequency from human infectious processes by some investigators. The aim of this study is to elucidate the isolation rate and antimicrobial susceptibility of recent clinical Klebsiella isolates. METHOD: For the clinical Klebsiella isolates during the period of June 1999 to May 2000, isolation frequency of Klebsiella species by specimen, departments, age, and sex were analyzed. And antimicrobial susceptibilities were also analyzed. RESULT: Isolation rate of Klebsiella in order of decreasing frequency were K. pneumoniae (74:7%), K. oxytoca (12.1%), K. ozaenae(1.7%), K. planticola(1.0%), K. terngena(0.9%), and K, ornithinolytica (0.7%), respectively. K. rhinoscleromatis was not isolated. Compared with outpatients, increase of resistance rates of inpatients's Klebsiella isolates were 10% in ciprofloxacin, 15% in cefoperazone/sulbactam, and the others were ranged from 24% to 31%. Isolation rate of ESBL producing K. pneumoniae by double disk (DD) synergy test was 41%, and detection rates by antimicrobial agents were as follows: cefotaxime (95%), aztreonam (58%), and ceftriaxone (37%). Antimicrobial susceptibility rate with the exception of ampicillin and imipenem decreased from the range of 81%-96% on admission day to 29-62% after one week on admission. CONCLUSION: The isolation rates of K. planticola and K. terrigena were less than 1%. The proportion of ESBL producing K. pneumoniae was 41 %. And the vast majority of multidrug resistant Klebsiella including ESBL producing strains are acquired by hospitalization.
Ampicillin
;
Anti-Infective Agents
;
Aztreonam
;
beta-Lactamases
;
Cefotaxime
;
Ceftriaxone
;
Ciprofloxacin
;
Epidemiology*
;
Hospitalization
;
Humans
;
Imipenem
;
Incidence
;
Klebsiella pneumoniae
;
Klebsiella*
;
Outpatients
;
Pneumonia
;
Research Personnel
2.Identificatiion,Antimicrobial Susceptibility an Epidemiology of Klebsiella species Isolated from Clinical Specimen.
Young UH ; Soon Deok PARK ; Jeong Seog SON ; Hyeun Gyeo LEE ; Hyun Mi CHO ; Kap Jun YOON ; Hyo Youl KIM
Korean Journal of Clinical Microbiology 2000;3(2):99-110
BACKGROUND: In recent years, the incidence of extended-spectrum beta-lactamase (ESBL) producing Klebsiella has been steadily increased, and the newer species K. planticola and K terrigena, formerly regarded as nonpathogen, have been reported with astonishing frequency from human infectious processes by some investigators. The aim of this study is to elucidate the isolation rate and antimicrobial susceptibility of recent clinical Klebsiella isolates. METHOD: For the clinical Klebsiella isolates during the period of June 1999 to May 2000, isolation frequency of Klebsiella species by specimen, departments, age, and sex were analyzed. And antimicrobial susceptibilities were also analyzed. RESULT: Isolation rate of Klebsiella in order of decreasing frequency were K. pneumoniae (74:7%), K. oxytoca (12.1%), K. ozaenae(1.7%), K. planticola(1.0%), K. terngena(0.9%), and K, ornithinolytica (0.7%), respectively. K. rhinoscleromatis was not isolated. Compared with outpatients, increase of resistance rates of inpatients's Klebsiella isolates were 10% in ciprofloxacin, 15% in cefoperazone/sulbactam, and the others were ranged from 24% to 31%. Isolation rate of ESBL producing K. pneumoniae by double disk (DD) synergy test was 41%, and detection rates by antimicrobial agents were as follows: cefotaxime (95%), aztreonam (58%), and ceftriaxone (37%). Antimicrobial susceptibility rate with the exception of ampicillin and imipenem decreased from the range of 81%-96% on admission day to 29-62% after one week on admission. CONCLUSION: The isolation rates of K. planticola and K. terrigena were less than 1%. The proportion of ESBL producing K. pneumoniae was 41 %. And the vast majority of multidrug resistant Klebsiella including ESBL producing strains are acquired by hospitalization.
Ampicillin
;
Anti-Infective Agents
;
Aztreonam
;
beta-Lactamases
;
Cefotaxime
;
Ceftriaxone
;
Ciprofloxacin
;
Epidemiology*
;
Hospitalization
;
Humans
;
Imipenem
;
Incidence
;
Klebsiella pneumoniae
;
Klebsiella*
;
Outpatients
;
Pneumonia
;
Research Personnel
3.¹H-NMR Analysis of Metabolic Changes Induced by Snf1/AMP-Activated Protein Kinase During Environmental Stress Responses
Jiyoung KIM ; Junsang OH ; Deok Hyo YOON ; Gi Ho SUNG
Mycobiology 2019;47(3):346-349
AMP-activated protein kinase sucrose non-fermenting 1 (Snf1) is a representative regulator of energy status that maintains cellular energy homeostasis. In addition, Snf1 is involved in the mediation of environmental stress such as salt stress. Snf1 regulates metabolic enzymes such as acetyl-CoA carboxylase, indicating a possible role for Snf1 in metabolic regulation. In this article, we performed nuclear magnetic resonance (NMR) spectroscopy to profile the metabolic changes induced by Snf1 under environmental stress. According to our NMR data, we suggest that Snf1 plays a role in regulating cellular concentrations of a variety of metabolites during environmental stress responses.
4.Use of Boronic Acid Disks for the Detection of Extended-spectrum beta-lactamase and AmpC beta-lactamase in Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca and Proteus mirabilis.
Soon Deok PARK ; Young UH ; In Ho JANG ; Ohgun KWON ; Kap Jun YOON ; Hyo Youl KIM
Korean Journal of Clinical Microbiology 2009;12(1):24-29
BACKGROUND: Accurate detection of organisms producing extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase is very important for treatment of patients. However, unlike the ESBL confirmatory test, there are no guidelines for detection of organisms producing AmpC beta-lactamase. We evaluated a detection method using boronic acid (BA) for ESBL and AmpC beta-lactamase. METHODS: Clinical isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus mirabilis showing intermediate resistance or resistance to cefoxitin (FOX) or positive for ESBL were tested. A > or =5 mm increase in zone diameter of ceftazidime/clavulanic acid/BA (CAZ/CA/BA) and/or cefotaxime/clavulanic acid/BA (CTX/CA/BA) versus CAZ/BA and/or CTX /BA was considered positive for ESBL. Likewise, a > or =5 mm increase in zone diameter of FOX/BA and/or cefotetan/BA (CTT/BA) versus FOX and/or CTT alone was considered positive for AmpC beta-lactamase. RESULTS: Among 622 clinical isolates, ESBL positive rates by the CLSI ESBL confirmatory test or by the BA method were 18.1% or 18.4% for E. coli, 38.3% or 40.4% for K. pneumoniae, 8.7% or 8.7% for K. oxytoca, and 14.8% or 14.8% for P. mirabilis, respectively. AmpC beta-lactamase positive rates using the BA method were 3.7% for E. coli, 33.3% for K. pneumoniae, 0% for K. oxytoca, and 7.4% for P. mirabilis. The detection rates of coproducing ESBL and AmpC beta-lactamase were 2.4% in E. coli 27.1% in K. pneumoniae, and 3.7% in P. mirabilis. CONCLUSION: The ESBL confirmatory method using BA was found to enhance the detection of ESBLs, even when potentially masked by AmpC beta-lactamase.
Bacterial Proteins
;
beta-Lactamases
;
Boron
;
Cefoxitin
;
Escherichia
;
Escherichia coli
;
Humans
;
Klebsiella
;
Klebsiella oxytoca
;
Klebsiella pneumoniae
;
Masks
;
Mirabilis
;
Penicillinase
;
Pneumonia
;
Proteus
;
Proteus mirabilis
5.Inhibitory Activity of Cordyceps bassiana Extract on LPS-induced Inflammation in RAW 264.7 Cells by Suppressing NF-κB Activation.
Deok Hyo YOON ; Changwoo HAN ; Yuanying FANG ; Shankariah GUNDETI ; In Sook HAN LEE ; Won O SONG ; Ki Chul HWANG ; Tae Woong KIM ; Gi Ho SUNG ; Haeil PARK
Natural Product Sciences 2017;23(3):162-168
Cordyceps bassiana has long been used as an oriental medicine and reported to possess diverse biological activities. The fruiting bodies of Cordyceps bassiana was extracted with ethanol and then further fractionated with n-hexane, ethyl acetate, n-butanol and water. The butanol fraction from Cordyceps bassiana (CBBF) exhibited the most effective in anti-inflammatory activity in RAW 264.7 macrophages and the roles of CBBF on the anti-inflammation cascade in LPS-stimulated RAW 264.7 cells were studied. To investigate the mechanism by which CBBF inhibits NO, iNOS and COX-2, the activation of IκB and MAPKs in LPS-activated macrophage were examined. Our present results demonstrated that CBBF inhibits NO production and iNOS expression in LPS-stimulated RAW 264.7 macrophage cells, and these effects were mediated through the inhibition of IκB-α, JNK and p38 phosphorylation. Also, CBBF suppressed activation of MAPKs including p38 and SAPK/JNK. Furthermore, CBBF significantly suppressed LPS-induced intracellular ROS generation. Its inhibition on iNOS expression, together with its antioxidant activity, may support its anti-inflammatory activity. Thus Cordyceps bassiana can be used as a useful medicinal food or drug for further studies.
1-Butanol
;
Cordyceps*
;
Ethanol
;
Fruit
;
Inflammation*
;
Macrophages
;
Medicine, East Asian Traditional
;
Phosphorylation
;
RAW 264.7 Cells*
;
Water
6.A Case of Escherichia coli O157 and Campylobacter species Gastroenteritis.
Young UH ; Soon Deok PARK ; Gyu Yul HWANG ; Kap Jun YOON ; Hwang Min KIM ; Hyo Youl KIM
Korean Journal of Clinical Microbiology 2004;7(2):186-189
Verotoxin-producing Escherichia coli O157 is a primary cause of severe and bloody diarrhea. Campylobacter spp. are one of the commonly reported bacterial cause of gastrointestinal infections throughout the world. Only a few cases involving both E. coli O157 and Campylobacter species have been reported. The authors simultaneously isolated verotoxin-producing E. coli O157 and Campylobacter species from the stool of a 3 year-old male with bloody diarrhea, fever and abdominal pain.
Abdominal Pain
;
Campylobacter*
;
Child, Preschool
;
Diarrhea
;
Escherichia coli O157*
;
Escherichia coli*
;
Escherichia*
;
Fever
;
Gastroenteritis*
;
Humans
;
Male
;
Shiga Toxins
;
Shiga-Toxigenic Escherichia coli
7.Factors Influencing the False Positive Signals of Continuous Monitoring Blood Culture System.
Young UH ; In Ho JANG ; Soon Deok PARK ; Kab Seung KIM ; Dong Min SEO ; Kap Jun YOON ; Hee Kyoung CHOI ; Young Keun KIM ; Hyo Youl KIM
Annals of Clinical Microbiology 2014;17(2):58-64
BACKGROUND: The false positive signals of a continuous monitoring blood culture system (CMBCS) increase the reporting time and laboratory cost. This study aimed to determine the highly relevant variables that discriminate false positive signals from true positive signals in a CMBCS. METHODS: Among 184,363 blood culture sets (aerobic and anaerobic), the signal-positive samples according to a BACTEC FX system (Plus Aerobic/F, BDA; Plus Anaerobic/F, BDN) and BacT/Alert 3D system (Standard Aerobic, BSA; Standard Anaerobic, BSN) between April 2010 and November 2013 were classified into two groups: false positive or true positive signals. The data of 15 parameters between the two groups were then statistically compared. RESULTS: Among total blood cultures, the positive rates of CMBCS signals according to BDA, BDN, BSA, and BSN were 4.9%, 2.8%, 3.8%, and 3.2%, respectively. The false positive rates of CMBCS signals according to BDA, BDN, BSA, and BSN were 0.6%, 0.1%, 0.1%, and 0.1%, respectively. The blood volume, detection time, time interval between admission and test, C-reactive protein concentration, leukocyte count, delta neutrophil index, and mean peroxidase index showed statistically significant differences between the two groups. CONCLUSION: There were no variables with diagnostic sensitivity and specificity for discriminating the two groups. Therefore, analysis of bacterial growth curves produced by CMBCS is needed for early and effective detection of false positive signals.
Blood Volume
;
C-Reactive Protein
;
Leukocyte Count
;
Neutrophils
;
Peroxidase
8.Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study.
Seul LEE ; Moon Jin KIM ; Jin Seok KIM ; Sung Yong OH ; Seok Jin KIM ; Yoon Hyung KWON ; In Young CHUNG ; Jung Hun KANG ; Deok Hwan YANG ; Hye Jin KANG ; Dok Hyun YOON ; Won Seog KIM ; Hyo Jin KIM ; Cheolwon SUH
Blood Research 2015;50(4):242-247
BACKGROUND: Intraocular lymphoma (IOL) is a rare malignant lymphoma that most closely resembles a diffuse large B-cell lymphoma, and it is a subtype of primary central nervous system lymphoma (PCNSL). IOL is located inside the eye in the retina, uvea, and/or optic nerve. We retrospectively analyzed IOL patient data to identify treatment patterns and survival rates in Korea. METHODS: Cytological confirmation for a diagnosis of IOL was performed for all patients. The clinical data collected from medical records included Ann Arbor stage, International Prognostic Index, performance status, date of diagnosis, treatment modality and response, date of relapse, and date of last follow-up. RESULTS: Twenty patients who were diagnosed with IOL, between December 2007 and June 2014 at multiple centers in Korea, were included in the analysis. Four patients were diagnosed with IOL alone, not involving the CNS. Two patients with isolated IOL later developed PCNSL. Nine patients developed CNS lesions before the onset of ocular lymphoma. Five patients had simultaneous onset in the eye and CNS. Twelve patients were treated by intravitreal injection of methotrexate for IOL. The median progression-free survival (PFS) for patients was 19.7 months (95% CI, 8.7-30.7 mo). The estimated 3-year overall survival (OS) for all patients was 75.1%. CONCLUSION: Treatment for IOL patients included radiotherapy and intraocular chemotherapy. IOL patients showed favorable PFS and OS. These patients would require long-term follow-up to identify relapse and adverse effects of radiotherapy or intraocular chemotherapy.
Central Nervous System
;
Diagnosis
;
Disease-Free Survival
;
Drug Therapy
;
Follow-Up Studies
;
Humans
;
Intraocular Lymphoma*
;
Intravitreal Injections
;
Korea*
;
Lymphoma*
;
Lymphoma, B-Cell
;
Medical Records
;
Methotrexate
;
Optic Nerve
;
Radiotherapy
;
Recurrence
;
Retina
;
Retrospective Studies
;
Survival Rate
;
Uvea
9.A Case of Focal Autoimmune Chronic Pancreatitis Improved with Oral Steroid Therapy.
Sang Hyun PARK ; Jung Ho KIM ; Soon Joo KIM ; Jin Kyung RYU ; Sang Hyo SHIN ; Hyun Deok SHIN ; Chang Lae JO ; Tae Yoon LEE ; Sang Soo LEE ; Dong Wan SEO ; Sung Koo LEE ; Myung Hwan KIM
Korean Journal of Gastrointestinal Endoscopy 2007;34(3):179-183
Clinically, patients with pancreatic cancer and focal autoimmune chronic pancreatitis share many features, such as being elderly, painless jaundice, new-onset diabetes mellitus, and weight loss. Hence, it is difficult to differentiate between the two conditions. Nevertheless, it is very important to distinguish between focal autoimmune chronic pancreatitis and pancreatic cancer because they have different treatment modalities and prognoses. We encountered a case of a 72-year-old man who developed painless jaundice. The patient was diagnosed with focal autoimmune chronic pancreatitis instead of pancreatic cancer from the CT, ERCP, MRCP findings accompanying with an increased IgG4 level. The abnormalities in the clinical, laboratory, and radiological findings improved after 2 weeks of oral steroid treatment. After 3 months of oral steroid treatment, his disease showed further improvement. To our knowledge, this is a rare case of focal autoimmune chronic pancreatitis that improved with oral steroid treatment.
Aged
;
Cholangiopancreatography, Endoscopic Retrograde
;
Diabetes Mellitus
;
Humans
;
Immunoglobulin G
;
Jaundice
;
Pancreatic Neoplasms
;
Pancreatitis, Chronic*
;
Prognosis
;
Weight Loss
10.Bowel infarction due to intestinal mucormycosis in an immunocompetent patient.
Han Lim CHOI ; Yoon Mi SHIN ; Ki Man LEE ; Kang Hyeon CHOE ; Hyun Jeong JEON ; Ro Hyun SUNG ; Kyeong Seob SHIN ; Young Deok SHIN ; Hyo Yung YUN ; Young Jin SONG ; Jae Woon CHOI ; Dong Hee RYU
Journal of the Korean Surgical Society 2012;83(5):325-329
Mucormycosis is a fatal opportunistic fungal infection that typically occurs in immunocompromised patients. The classical manifestation of mucormycosis is a rhinocerebral infection, and although primary gastrointestinal infection is uncommon, it has an extremely high mortality rate in immunocompromised patients. Furthermore, cases of gastrointestinal mucormycosis in an immunocompetent host are rarely reported. Here, we describe our experience of a male patient, with no underlying disease, who succumbed to a bowel infarction caused by intestinal mucormycosis during mechanical ventilatory care for severe pneumonia and septic shock.
Humans
;
Immunocompetence
;
Immunocompromised Host
;
Infarction
;
Male
;
Mucormycosis
;
Pneumonia
;
Shock, Septic